GRPR and prostate carcinoma: Their potential for imaging GRPR expression was evaluated by in vitro competition binding, positron emission tomography (PET) imaging, and ex vivo biodistribution studies in a preclinical PC-3 prostate cancer model in mice, and compared with the gold standard, [68Ga]Ga-RM2.